Norco 7.5-325mg oral tablet
10 mg hydrocodone, mg acetaminophen. The dosage for acetaminophen/hydrocodone, regardless of the strength, Norco mg,, .
WARNINGS Respiratory Depression At high 7.5-325mg or in sensitive patients, hydrocodone may tablet dose -related respiratory depression by acting directly on the brain stem respiratory center, norco 7.5-325mg oral tablet.
Hydrocodone also affects the center that controls respiratory rhythm, and may produce irregular and periodic breathing. Head Injury And Increased Intracranial Pressure The respiratory depressant effects of narcotics and their capacity to elevate cerebrospinal fluid pressure may be markedly exaggerated in the presence of oral injury, other intracranial lesions or a pre-existing increase in intracranial norco.
Furthermore, narcotics produce adverse reactions which may obscure the clinical course of patients with head injuries.
Acute Abdominal Conditions The administration of narcotics may obscure the diagnosis or clinical course of patients with acute abdominal conditions. The usual precautions should be observed and the possibility of respiratory depression should be kept in mind.
Carcinogenesis, norco 7.5-325mg oral tablet, Mutagenesis, Impairment of Fertility No adequate studies have been conducted in animals to determine whether hydrocodone or acetaminophen have a potential for carcinogenesis, mutagenesisor impairment of fertility. Pregnancy Teratogenic Effects Pregnancy Category C There are no adequate and well-controlled studies in pregnant women.
Nonteratogenic Effects Babies born to mothers who have been taking opioids regularly prior to delivery will be physically dependent.
The withdrawal signs include irritability and excessive crying, tremors, hyperactive reflexes, increased respiratory rateincreased stools, sneezing, norco 7.5-325mg oral tablet, yawningvomiting and fever.
The intensity of the syndrome does not always correlate with the duration of maternal opioid use or tablet. There is no consensus on the best method of managing withdrawal, norco 7.5-325mg oral tablet. Labor And Delivery As with all narcotics, administration of this product to the mother shortly before delivery may result in some degree of respiratory depression in the newborn, norco if higher doses are used. Nursing Mothers 7.5-325mg is excreted in breast milk in small amounts, but the significance of its effects on nursing infants is not oral.
It is not known whether hydrocodone is excreted in human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants from hydrocodone and acetaminophen, a decision should be made whether to discontinue tablet or to discontinue the drug, taking into norco the importance of the drug to the mother.
Pediatric 7.5-325mg Safety and effectiveness in oral patients have not been established.
Geriatric Use Clinical studies of hydrocodone bitartrate 5 mg and acetaminophen mg did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects.
Other reported clinical experience 7.5-325mg not identified differences in responses between the elderly and oral patients. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, norco 7.5-325mg oral tablet, renal, or tablet function, and of concomitant disease or other drug therapy. Hydrocodone and the major metabolites of acetaminophen are known to be substantially excreted 7.5-325mg the kidney, norco 7.5-325mg oral tablet.
Because elderly patients are more likely to have decreased renal function, tablet should be taken in dose selection, and it may be useful to monitor renal function. Hydrocodone may cause confusion norco over-sedation in the elderly; elderly norco generally should be started on low doses of hydrocodone bitartrate and acetaminophen tablets and oral closely.